Sho Nishimura
Kyushu University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sho Nishimura.
Annals of Surgery | 2017
Hiroshi Saeki; Satoshi Tsutsumi; Hirotada Tajiri; Takafumi Yukaya; Ryosuke Tsutsumi; Sho Nishimura; Yu Nakaji; Kensuke Kudou; Shingo Akiyama; Yuta Kasagi; Ryota Nakanishi; Yuichiro Nakashima; Masahiko Sugiyama; Kippei Ohgaki; Hideto Sonoda; Eiji Oki; Yoshihiko Maehara
Objective: The objective of this study was to elucidate the impact of postoperative complications on long-term survival after curative resection for esophageal squamous cell carcinoma. Background: The relation between postoperative complications and long-term survival after curative surgery for esophageal squamous cell carcinoma is controversial; thus, this issue should be resolved with a large-scale, well-designed study. Methods: Clinicopathological features and survival of 580 consecutive patients who received curative resection for esophageal squamous cell carcinoma were investigated according to the development of postoperative pulmonary complications and anastomotic leakage. Results: The 5-year survival rates of patients with pStage 0, I, and II disease with postoperative complications (n = 116) were significantly poorer than those of patients without postoperative complications (n = 288) (overall 69.6% vs 46.9%, P < 0.0001; disease-specific; 76.7% vs 58.9%, P < 0.0022), whereas no differences were found in patients with pStage III and IV disease (n = 176). In the univariate and multivariate analyses for disease-specific survival, pT3, pT4, pN positivity, and development of postoperative complications were significant prognostic factors in all patients. Also, when the analysis was limited to the pStage 0, I, and II patients, development of postoperative complications, and pT3, pT4, and pN positivity, were found to be independent poor prognostic factors in multivariate analyses (hazard ratio: 1.56, 95% confidence interval, 1.01–2.41, P = 0.0476). Conclusions: The development of postoperative complications is an independent disease-specific poor prognostic factor after curative resection for patients with less-advanced esophageal squamous cell carcinoma.OBJECTIVE The objective of this study was to elucidate the impact of postoperative complications on long-term survival after curative resection for esophageal squamous cell carcinoma. BACKGROUND The relation between postoperative complications and long-term survival after curative surgery for esophageal squamous cell carcinoma is controversial; thus, this issue should be resolved with a large-scale, well-designed study. METHODS Clinicopathological features and survival of 580 consecutive patients who received curative resection for esophageal squamous cell carcinoma were investigated according to the development of postoperative pulmonary complications and anastomotic leakage. RESULTS The 5-year survival rates of patients with pStage 0, I, and II disease with postoperative complications (n = 116) were significantly poorer than those of patients without postoperative complications (n = 288) (overall 69.6% vs 46.9%, P < 0.0001; disease-specific; 76.7% vs 58.9%, P = 0.0022), whereas no differences were found in patients with pStage III and IV disease (n = 176). In the univariate and multivariate analyses for disease-specific survival, pT3, pT4, pN positivity, and development of postoperative complications were significant prognostic factors in all patients. Also, when the analysis was limited to the pStage 0, I, and II patients, development of postoperative complications, and pT3, pT4, and pN positivity, were found to be independent poor prognostic factors in multivariate analyses (hazard ratio: 1.56, 95% confidence interval, 1.01-2.41, P = 0.0476). CONCLUSIONS The development of postoperative complications is an independent disease-specific poor prognostic factor after curative resection for patients with less-advanced esophageal squamous cell carcinoma.
Annals of Surgery | 2017
Hiroshi Saeki; Satoshi Tsutsumi; Takafumi Yukaya; Hirotada Tajiri; Ryosuke Tsutsumi; Sho Nishimura; Yu Nakaji; Kensuke Kudou; Shingo Akiyama; Yuta Kasagi; Yuichiro Nakashima; Masahiko Sugiyama; Hideto Sonoda; Kippei Ohgaki; Eiji Oki; Ryuji Yasumatsu; Torahiko Nakashima; Masaru Morita; Yoshihiko Maehara
Objective: The objectives of this retrospective study were to elucidate the clinicopathological features and recent surgical results of cervical esophageal cancer. Summary Background Data: Cervical esophageal cancer has been reported to have a dismal prognosis. Accurate knowledge of the clinical characteristics of cervical esophageal cancer is warranted to establish appropriate therapeutic strategies. Methods: The clinicopathological features and treatment results of 63 consecutive patients with cervical esophageal cancer (Ce group) who underwent surgical resection from 1980 to 2013 were analyzed and compared with 977 patients with thoracic or abdominal esophageal cancer (T/A group) who underwent surgical resection during that time. Results: Among the patients who received curative resection, the 5-year overall and disease-specific survival rates of the Ce patients were significantly better than those of the T/A patients (overall: 77.3% vs 46.5%, respectively, P = 0.0067; disease-specific: 81.9% vs 55.8%, respectively, P = 0.0135). Although total pharyngo-laryngo-esophagectomy procedures were less frequently performed in the recent period, the rate of curative surgical procedures was markedly higher in the recent period (2000–1013) than that in the early period (1980–1999) (44.4% vs 88.9%, P = 0.0001). The 5-year overall survival rate in the recent period (71.5%) was significantly better than that in the early period (40.7%, P = 0.0342). Conclusions: Curative resection for cervical esophageal cancer contributes to favorable outcomes compared with other esophageal cancers. Recent surgical results for cervical esophageal cancer have improved, and include an increased rate of curative resection and decreased rate of extensive surgery.
Surgical Laparoscopy Endoscopy & Percutaneous Techniques | 2016
Sho Nishimura; Eiji Oki; Satoshi Tsutsumi; Yasuo Tsuda; Masahiko Sugiyama; Yuichiro Nakashima; Hideto Sonoda; Kippei Ohgaki; Hiroshi Saeki; Yoshihiko Maehara
Background: Laparoscopic distal gastrectomy has become an established minimally invasive treatment for gastric cancer since it was first reported in 1994. Materials and Methods: We retrospectively assessed the clinical outcomes of 248 patients who had undergone open distal gastrectomy (ODG), laparoscopic-assisted distal gastrectomy (LADG), and totally laparoscopic distal gastrectomy (TLDG) for gastric cancer. Results and Conclusions: TLDG showed superiority in terms of blood loss, reconstruction options, and postoperative recovery compared with ODG and LADG. Especially, the mean operating time in the TLDG group was significantly shorter than that of the LADG group (P=0.003). Book-binding technique used in TLDG was one of the reasons of this result. The only inferior aspect of TLDG was the longer operating time compared with ODG; TLDG had no disadvantages compared with LADG. Although the operating time and long-term outcome remain problems, we suggest that TLDG has the potential to serve as an optimal operative method.
Journal of Reproduction and Development | 2014
Kazuki Yamagami; Nobuhiko Yamauchi; Kaiyu Kubota; Sho Nishimura; Vishwajit S. Chowdhury; Ken-ichi Yamanaka; Masashi Takahashi; Shoji Tabata; Masa-aki Hattori
The forkhead box a (Foxa) protein family has been found to play important roles in mammals. Recently, the expression of Foxa2 was reported in the mouse uterus, and it was reported to be involved in regulation of implantation. However, the regulation of Foxa2 expression in the uterus is still poorly understood. Therefore, the present study was conducted to investigate the expressional profiles of Foxa2 in the rat uterus during the estrus cycle and pregnancy. Furthermore, the effect of steroid hormones and Hedgehog protein on the expression of Foxa2 was analyzed in vivo and in vitro. In this study, the level of expression of Foxa2 was low in the rat uterus during the different stages of the estrus cycle. However, the expression increased transiently during early pregnancy at 3.5 days post coitus (dpc) and decreased at 5.5 dpc. In ovariectomized rats, P4 treatment had no effect on the expression of Foxa2 compared with the expression in control animals. Moreover, the expression of Foxa2 in cultured epithelial cells was not increased by P4 treatment in vitro. However, Foxa2 expression was significantly decreased in the rat uterus after 24 h of E2 treatment. Treatment of cells with a recombinant Hedgehog protein significantly increased the expression of Foxa2. These results suggest that the expression of Foxa2 may transiently increase just before the implantation and it may be regulated by E2 and Hedgehog protein.
Surgical Case Reports | 2016
Daisuke Taniguchi; Hiroshi Saeki; Yuichiro Nakashima; Ryosuke Tsutsumi; Sho Nishimura; Kensuke Kudou; Yu Nakaji; Hirotada Tajiri; Satoshi Tsutsumi; Takafumi Yukaya; Ryota Nakanishi; Masahiko Sugiyama; Hideto Sonoda; Kippei Ohgaki; Eiji Oki; Yoshihiko Maehara
A 65-year-old man with cT3N2M0 stage III cervical esophageal cancer underwent subtotal esophagectomy and gastric tube reconstruction through the retrosternal route after neoadjuvant chemoradiotherapy. The anastomosis was located adjacent to the left side of the trachea, and a circular stapler was used for anastomosis. Postoperative anastomotic leakage occurred, and an esophagotracheal fistula between the esophagogastric anastomotic site and cartilage portion of the trachea was observed on postoperative day 44. The patient underwent division of the fistula, direct suturing of the anastomotic leakage site, left pectoralis major muscle flap placement, and tracheotomy. He was discharged home on postoperative day 120 on an oral diet. All previous reports of tracheobronchial fistula describe the occurrence of the fistula at the membranous portion of the trachea. The formation of a fistula between the esophagogastric anastomotic site and cartilage portion of the trachea is considered a possible complication when a high esophagogastric anastomosis is created.
Cancer Medicine | 2017
Sho Nishimura; Eiji Oki; Koji Ando; Makoto Iimori; Yu Nakaji; Yuichiro Nakashima; Hiroshi Saeki; Yoshinao Oda; Yoshihiko Maehara
Chromosomal instability (CIN), characterized by aneuploidy, is a major molecular subtype of gastric cancer. The deubiquitinase USP44 is an important regulator of APC activation in the spindle checkpoint and leads to proper chromosome separation to prevent aneuploidy. Aberrant expression of USP44 leads CIN in cells; however, the correlation between USP44 and DNA aneuploidy in gastric cancer is largely unknown. We analyzed USP44 expression in 207 patients with gastric cancer by immunohistochemistry and found that the proportion of USP44 expression was higher in gastric cancer tumors (mean, 39.6%) than in gastric normal mucosa (mean, 14.6%) (P < 0.0001). DNA aneuploidy was observed in 124 gastric cancer cases and high USP44 expression in cancer strongly correlated with DNA aneuploidy (P = 0.0005). The overall survival was significantly poorer in the high USP44 expression group compared with the low USP44 group (P = 0.033). Notably, USP44 expression had no prognostic impact in the diploid subgroup; however, high USP44 expression was a strong poor prognostic factor for progression‐free survival (P = 0.018) and overall survival (P = 0.036) in the aneuploid subgroup. We also confirmed that stable overexpression of USP44 induced somatic copy‐number aberrations in hTERT‐RPE‐1 cells (50.6%) in comparison with controls (6.6%) (P < 0.0001). Collectively, our data show USP44 has clinical impact on the induction of DNA aneuploidy and poor prognosis in the CIN gastric cancer subtype.
Annals of Surgical Oncology | 2017
Kensuke Kudou; Hiroshi Saeki; Yuichiro Nakashima; Keitaro Edahiro; Shotaro Korehisa; Daisuke Taniguchi; Ryosuke Tsutsumi; Sho Nishimura; Yu Nakaji; Shingo Akiyama; Hirotada Tajiri; Ryota Nakanishi; Junji Kurashige; Masahiko Sugiyama; Eiji Oki; Yoshihiko Maehara
Cell and Tissue Research | 2010
Kaiyu Kubota; Nobuhiko Yamauchi; Kazuki Yamagami; Sho Nishimura; Takafumi Gobaru; Ken Ichi Yamanaka; Chris Wood; Tomoki Soh; Masashi Takahashi; Masa-aki Hattori
Anticancer Research | 2015
Sho Nishimura; Hiroshi Saeki; Tomonori Nakanoko; Yuta Kasagi; Yasuo Tsuda; Yoko Zaitsu; Koji Ando; Yuichiro Nakashima; Yu Imamura; Kippei Ohgaki; Eiji Oki; Saiji Ohga; Katsumasa Nakamura; Masaru Morita; Yoshihiko Maehara
Surgical Case Reports | 2016
Satoshi Tsutsumi; Hiroshi Saeki; Yuichiro Nakashima; Yu Nakaji; Kensuke Kudou; Ryosuke Tsutsumi; Sho Nishimura; Shingo Akiyama; Hirotada Tajiri; Takafumi Yukaya; Kimihiro Tanaka; Ryota Nakanishi; Masahiko Sugiyama; Kippei Ohgaki; Hideto Sonoda; Minako Hirahashi; Eiji Oki; Masaru Morita; Yoshinao Oda; Yoshihiko Maehara